PubMedCrossRef 41. Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA: Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with this website Adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 2008, 72:695–701.PubMedCrossRef 42. Lally BE, Detterbeck FC, Geiger AM, Thomas CR Jr, Machtay M, Miller AA, Wilson LD, Oaks TE, Petty WJ, Robbins ME, Blackstock AW: The risk of death from heart disease in patients with nonsmall cell lung

cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer 2007, 110:911–917.PubMedCrossRef 43. Matsuguma H, Nakahara R, Ishikawa Y, Suzuki H, Inoue K, Katano S, Yokoi K: Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung BAY 1895344 ic50 cancer: focusing on an effect of the number of mediastinal lymph node stations involved. Interact Cardiovasc Thorac Surg 2008, 7:573–577.PubMedCrossRef 44. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, Pairolero PC, Allen MS, Lange CM, Li H: Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks. Ann Thorac Surg 1997, 64:1402–1407.

discussion 1407–1408PubMedCrossRef 45. Pepe C, Hasan B, selleck screening library Winton TL, Olopatadine Seymour L, Graham B, Livingston RB, Johnson DH, Rigas JR, Ding K, Shepherd FA: Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 2007, 25:1553–1561.PubMedCrossRef 46. Fruh M, Rolland E,

Pignon JP, Seymour L, Ding K, Tribodet H, Winton T, Le Chevalier T, Scagliotti GV, Douillard JY, et al.: Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. J Clin Oncol 2008, 26:3573–3581.PubMedCrossRef 47. Fervers B: Chemotherapy in elderly patients with resected stage II-IIIA lung cancer. BMJ 343:d4104. 48. Alam N, Shepherd FA, Winton T, Graham B, Johnson D, Livingston R, Rigas J, Whitehead M, Ding K, Seymour L: Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer 2005, 47:385–394.PubMedCrossRef 49. Strauss GM, Herndon JE, Maddaus MA, Johnstone DW, Johnson EA, Watson DM, Sugarbaker DJ, Schilsky RA, Vokes EE, Green MR, The Calgb RTOG: Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633. ASCO Meeting Abstracts 2006, 24:7007. 50. Besse B, Le Chevalier T: Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect? J Clin Oncol 2008, 26:5014–5017.PubMedCrossRef 51.